-
摘要: 毛母细胞瘤(trichoblastoma,TB)是一种罕见的毛发生殖细胞皮肤附件肿瘤,罕见的皮肤滤泡肿瘤,分化于毛胚上皮,常被视为良性皮肤肿瘤,但局限性差且具有局部浸润性生长模式。TB好发于头部和颈部区域,尤其是面部,临床表现为生长缓慢、边界清晰及隆起的结节。TB常规以手术治疗为主,由于目前缺乏普遍接受的治疗指南或方案,术后复发率高,为临床治愈增加了一定的难度。本研究报道1例65岁女性患者,发现右侧外耳道口及耳甲腔肿物并反复破溃流脓,最初误诊为外耳道炎,以常规抗感染治疗,症状未缓解并逐渐加重后来我院就诊。该病例所展现的病症极为罕见,因此,及时且准确的诊断与治疗对此类疫病的诊疗和预后至关重要。Abstract: Trichoblastoma(TB) is a rare germ cell skin adnexal tumor of the hair, and it is a rare follicular tumor of the skin that differentiates from the hair germ epithelium and is often regarded as a benign skin tumorHowever, it is poorly confined and has a local infiltrative growth pattern. tb occurs in the head and neck region, especially in the face, and presents clinically as a slow growing, well-defined and elevated nodule. TB is routinely treated surgically. Due to the lack of universally accepted treatment guidelines or protocols, the recurrence rate after surgery is high, which makes clinical cure more difficult. In this study, a 65-year-old female patient was found to have a swelling with recurrent rupture and pus flow from the right external auditory canal opening and the auricular cavity. After initial misdiagnosis as otitis externa, she was treated with conventional anti-infective therapy, but her symptoms did not resolve and gradually worsened before coming to our hospital. The condition presented in this case is relativelyrare, therepre, timely and accurate diagnosis and treatment are crucial for prognosis improvement of such diseases.
-
Key words:
- trichoblastoma /
- hair-derived tumor /
- benign tumor of the ear nail cavity /
- diagnosis /
- treatment
-
-
[1] Cao Z, Liu Y, Wei G, et al. Basal Cell Carcinoma or Trichoblastoma? Two Cases of Nasal Nodules Difficult to Distinguish[J]. Indian J Dermatol, 2022, 67(4): 448-450.
[2] Sławińska M, Płaszczyńska A, Lakomy J, et al. Significance of Dermoscopy in Association with Clinical Features in Differentiation of Basal Cell Carcinoma and Benign Trichoblastic Tumours[J]. Cancers(Basel), 2022, 14(16): 3964.
[3] Kolm I, Kastnerova L, Konstantinova AM, et al. Trichoblastoma: A Consecutive Series of 349 Sporadic Cases Analyzed by Ackerman Subtypes[J]. Am J Dermatopathol, 2021, 43(12): 887-897. doi: 10.1097/DAD.0000000000001895
[4] Pampena R, Peccerillo F, Marghoob NG, et al. Peritumoural clefting as a key feature in differentiating basal cell carcinoma from trichoblastoma through in vivo reflectance confocal microscopy[J]. J Eur Acad Dermatol Venereol, 2019, 33(5): e201-e203.
[5] Boettler MA, Shahwan KT, Abidi NY, et al. Trichoblastic carcinoma: a comprehensive review of the literature[J]. Arch Dermatol Res, 2022, 314(5): 399-403. doi: 10.1007/s00403-021-02241-y
[6] Zeller KA, Billmire DF. Trichoblastoma: management of a rare skin lesion[J]. J Pediatr Surg, 2012, 47(1): 250-252. doi: 10.1016/j.jpedsurg.2011.10.068
[7] Pitarch G, Botella-Estrada R. Dermoscopic Findings in Trichoblastoma[J]. Actas Dermosifiliogr, 2015, 106(9): e45-e48. doi: 10.1016/j.ad.2015.01.017
[8] Loh SH, Lew BL, Sim WY. Composite Tumor Associating Trichoblastoma and Seborrheic Keratosis[J]. Ann Dermatol, 2015, 27(5): 601-604. doi: 10.5021/ad.2015.27.5.601
[9] Kim HC, Sohng SH, Shin DH, et al. Immunohistochemical expression of cytokeratin 15, cytokeratin 19, follistatin, and Bmi-1 in basal cell carcinoma[J]. Int J Dermatol, 2016, 55(1): 36-44. doi: 10.1111/ijd.12771
[10] Umbert P, Muñoz JF. False-negative tumor-free margins following mohs surgery for aggressive trichoblastoma[J]. Am J Dermatopathol, 2012, 34(3): 255-258. doi: 10.1097/DAD.0b013e318213f80d
[11] Giang J, Mooyaart AL, Martens-de Kemp SR, et al. Hedgehog pathway mutations are involved in the pathogenesis of plaque-type "trichoblastoma": A report of two cases[J]. J Cutan Pathol, 2023, 50(7): 674-680. doi: 10.1111/cup.14389
[12] Rashid M, van der Horst M, Mentzel T, et al. ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma[J]. Nat Commun, 2019, 10(1): 2213. doi: 10.1038/s41467-019-09979-0
[13] Pickering CR, Zhou JH, Lee JJ, et al. Mutational landscape of aggressive cutaneous squamous cell carcinoma[J]. Clin Cancer Res, 2014, 20(24): 6582-6592. doi: 10.1158/1078-0432.CCR-14-1768
[14] South AP, Purdie KJ, Watt SA, et al. NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis[J]. J Invest Dermatol, 2014, 134(10): 2630-2638. doi: 10.1038/jid.2014.154
[15] Kervarrec T, Pissaloux D, Poilane J, et al. Recurrent FOXK1: : GRHL and GPS2: : GRHL fusions in trichogerminoma[J]. J Pathol, 2022, 257(1): 96-108. doi: 10.1002/path.5872
[16] Pogorzelska-Antkowiak A, Antkowiak R, Poloczek R. Trichoblastoma in reflectance confocal microscopy[J]. Australas J Dermatol, 2023, 64(1): e89-e90.
[17] Kocaman N, Yuksel EI, Demir B, et al. Two Novel Biomarker Candidates for Differentiating Basal Cell Carcinoma from Trichoblastoma; Asprosin and Meteorine Like Peptide[J]. Tissue Cell, 2022, 76: 101752. doi: 10.1016/j.tice.2022.101752
[18] Patel P, Nawrocki S, Hinther K, et al. Trichoblastomas Mimicking Basal Cell Carcinoma: The Importance of Identification and Differentiation[J]. Cureus, 2020, 12(5): e8272.
[19] Demant M, Saltvig I, Trøstrup H, et al. Don't Judge a Tumor by Its Biopsy![J]. Case Rep Dermatol, 2020, 12(3): 266-274. doi: 10.1159/000509764
[20] Requena C, Requena L, Kazakov DV, et al. Multiple facial plaque variant of trichoblastoma[J]. J Cutan Pathol, 2019, 46(4): 285-289. doi: 10.1111/cup.13416
[21] Weiland T, Sadoghi B, Pondorfer P, et al. Trichoblastic carcinosarcoma of the neck: Case report and molecular analysis of a seldom, relapsing entity and a review of the literature[J]. J Dermatol, 2023, 50(5): 700-704. doi: 10.1111/1346-8138.16716
[22] Vega Memije ME, Luna EM, de Almeida OP, et al. Immunohistochemistry panel for differential diagnosis of Basal cell carcinoma and trichoblastoma[J]. Int J Trichology, 2014, 6(2): 40-44. doi: 10.4103/0974-7753.138583
[23] 夏鹏, 吴发印, 黄志权, 等. 巨大结节与角化型面部基底细胞癌1例[J]. 临床耳鼻咽喉头颈外科杂志, 2022, 36(4): 307-309. https://lceh.whuhzzs.com/article/doi/10.13201/j.issn.2096-7993.2022.04.015
[24] Bi Y, Shi X, Chen D, et al. CD133, but Not CD44, May Serve as a Novel Biomarker for Differential Diagnosis Between Basal Cell Carcinoma and Trichoblastomas[J]. Clin Cosmet Investig Dermatol, 2022, 15: 1517-1526. doi: 10.2147/CCID.S373331
[25] Zhang ZC, Hu J, Kong YY, et al. [Application of immunohistochemical staining of bcl-2, Ber-EP4, CD10, CK20, and Ki-67 in differential diagnosis between trichoblastoma and basal cell carcinoma][J]. Zhonghua Bing Li Xue Za Zhi, 2021, 50(4): 376-381.
[26] Stanoszek LM, Wang GY, Harms PW. Histologic Mimics of Basal Cell Carcinoma[J]. Arch Pathol Lab Med, 2017, 141(11): 1490-1502. doi: 10.5858/arpa.2017-0222-RA
[27] Battistella M, Peltre B, Cribier B. PHLDA1, a follicular stem cell marker, differentiates clear-cell/granular-cell trichoblastoma and clear-cell/granular cell basal cell carcinoma: a case-control study, with first description of granular-cell trichoblastoma[J]. Am J Dermatopathol, 2014, 36(8): 643-650. doi: 10.1097/DAD.0b013e31828a31ae
[28] Owen JL, Liu W, Croitoru A, et al. Aggressive subcutaneous trichoblastomas successfully treated with Mohs micrographic surgery[J]. Australas J Dermatol, 2019, 60(3): e249-e251.
[29] Fusumae T, Tanese K, Takeuchi A, et al. High-grade trichoblastic carcinoma arising through malignant transformation of trichoblastoma: Immunohistochemical analysis and the expression of p53 and phosphorylated AKT[J]. J Dermatol, 2019, 46(1): 57-60. doi: 10.1111/1346-8138.14686
[30] Leblebici C, Bambul Sıǧırcı B, Kelten Talu C, et al. CD10, TDAG51, CK20, AR, INSM1, and Nestin Expression in the Differential Diagnosis of Trichoblastoma and Basal Cell Carcinoma[J]. Int J Surg Pathol, 2019, 27(1): 19-27. doi: 10.1177/1066896918781719
[31] Pozo L, Diaz-Cano SJ. Trichogerminoma: further evidence to support a specific follicular neoplasm[J]. Histopathology, 2005, 46(1): 108-110. doi: 10.1111/j.1365-2559.2005.01955.x
[32] Leeman A, de Cuba E, Jaspars LH, et al. A Low-Grade Trichoblastic Carcinoma Treated with Mohs Micrographic Surgery[J]. Case Rep Dermatol, 2021, 13(1): 129-133. doi: 10.1159/000512871
[33] Al Mushcab N, Husain R, Al Subaiei M, et al. Trichoblastoma mimicking basal cell carcinoma and the approach to its management: Case report[J]. Int J Surg Case Rep, 2021, 86: 106318. doi: 10.1016/j.ijscr.2021.106318
[34] Tellechea O, Cardoso JC, Reis JP, et al. Benign follicular tumors[J]. An Bras Dermatol, 2015, 90(6): 780-796. doi: 10.1590/abd1806-4841.20154114
-